A Common Genetic Mechanism in Malignant Bone Marrow Diseases

被引：14

作者：

Levine, Ross L. ^{[1
,2
]}

Carroll, Martin ^{[3
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA

[3] Univ Penn, Div Hematol & Oncol, Philadelphia, PA 19104 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2009年 / 360卷 / 22期

关键词：

MYELOPROLIFERATIVE DISORDERS; MUTATION; JAK2;

D O I：

10.1056/NEJMe0902257

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2355 / 2357

页数：3

共 9 条

[1] Mutation of JAK2 in the myeloproliferative disorders:: timing, clonality studies, cytogenetic associations, and role in leukemic transformation [J].

Campbell, Peter J. ;

Baxter, E. Joanna ;

Beer, Philip A. ;

Scott, Linda M. ;

Bench, Anthony J. ;

Huntly, Brian J. P. ;

Erber, Wendy N. ;

Kusec, Rajko ;

Larsen, Thomas Stauffer ;

Giraudier, Stephane ;

Le Bousse-Kerdiles, Marie-Caroline ;

Griesshammer, Martin ;

Reilly, John T. ;

Cheung, Betty Y. ;

Harrison, Claire N. ;

Green, Anthony R. .

BLOOD, 2006, 108 (10) :3548-3555

[2] SOME SPECULATIONS ON THE MYELOPROLIFERATIVE SYNDROMES [J].

DAMESHEK, W .

BLOOD, 1951, 6 (04) :372-375

[3] Mutation in TET2 in Myeloid Cancers [J].

Delhommeau, Francois ;

Dupont, Sabrina ;

Della Valle, Veronique ;

James, Chloe ;

Trannoy, Severine ;

Masse, Aline ;

Kosmider, Olivier ;

Le Couedic, Jean-Pierre ;

Robert, Fabienne ;

Alberdi, Antonio ;

Lecluse, Yann ;

Plo, Isabelle ;

Dreyfus, Francois J. ;

Marzac, Christophe ;

Casadevall, Nicole ;

Lacombe, Catherine ;

Romana, Serge P. ;

Dessen, Philippe ;

Soulier, Jean ;

Viguie, Franck ;

Fontenay, Michaela ;

Vainchenker, William ;

Bernard, Olivier A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (22) :2289-2301

[4] Myeloproliferative disorders [J].

Levine, Ross L. ;

Gilliland, D. Gary .

BLOOD, 2008, 112 (06) :2190-2198

[5] CLONAL EVOLUTION OF TUMOR-CELL POPULATIONS [J].

NOWELL, PC .

SCIENCE, 1976, 194 (4260) :23-28

[6]

NOWELL PC, 1960, SCIENCE, V132, P1497

[7] JAK2 inhibitor therapy in myeloproliferative disorders: rationale, preclinical studies and ongoing clinical trials [J].

Pardanani, A. .

LEUKEMIA, 2008, 22 (01) :23-30

[8] Leukemic blasts in transfon-ned JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation [J].

Theocharides, Alexandre ;

Boissinot, Marjorie ;

Girodon, Francois ;

Garand, Richard ;

Teo, Soon-Siong ;

Lippert, Eric ;

Talmant, Pascaline ;

Tichelli, Andre ;

Hermouet, Sylvie ;

Skoda, Radek C. .

BLOOD, 2007, 110 (01) :375-379

[9] Common 4q24 deletion in four cases of hematopoietic malignancy:: early stem cell involvement? [J].

Viguié, F ;

Aboura, A ;

Bouscary, D ;

Ramond, S ;

Delmer, A ;

Tachdjian, G ;

Marie, JP ;

Casadevall, N .

LEUKEMIA, 2005, 19 (08) :1411-1415

← 1 →